Tocilizumab for COVID-19: a real 'miracle drug'?Infect Dis (Lond). 2020 09; 52(9):681-682.ID
Links
MeSH
Pub Type(s)
Letter
Comment
Language
eng
PubMed ID
32644027
Citation
Nasim, Sundus, et al. "Tocilizumab for COVID-19: a Real 'miracle Drug'?" Infectious Diseases (London, England), vol. 52, no. 9, 2020, pp. 681-682.
Nasim S, Hashmi SH, Azim D, et al. Tocilizumab for COVID-19: a real 'miracle drug'? Infect Dis (Lond). 2020;52(9):681-682.
Nasim, S., Hashmi, S. H., Azim, D., Kumar, S., & Nasim, J. (2020). Tocilizumab for COVID-19: a real 'miracle drug'? Infectious Diseases (London, England), 52(9), 681-682. https://doi.org/10.1080/23744235.2020.1780307
Nasim S, et al. Tocilizumab for COVID-19: a Real 'miracle Drug'. Infect Dis (Lond). 2020;52(9):681-682. PubMed PMID: 32644027.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Tocilizumab for COVID-19: a real 'miracle drug'?
AU - Nasim,Sundus,
AU - Hashmi,Shariq Haider,
AU - Azim,Dua,
AU - Kumar,Sohail,
AU - Nasim,Jasia,
Y1 - 2020/06/17/
PY - 2020/7/10/entrez
PY - 2020/7/10/pubmed
PY - 2020/7/15/medline
SP - 681
EP - 682
JF - Infectious diseases (London, England)
JO - Infect Dis (Lond)
VL - 52
IS - 9
SN - 2374-4243
UR - https://www.unboundmedicine.com/medline/citation/32644027/Tocilizumab_for_COVID_19:_a_real_'miracle_drug'
DB - PRIME
DP - Unbound Medicine
ER -